Loic Maurel will begin serving as chief operating officer of ExonHit Therapeutics as of July 1. The company said that he will be appointed CEO at the next meeting of the French firm’s supervisory board.
 
Maurel previously served as president and CEO of Debiovision, a Canadian pharmaceutical development company. Before that, he was vice president of marketing and specialty business for Novartis Canada.
 
Maurel received his MD from the University of Bordeaux in France.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.